Literature DB >> 20668182

Cell-mediated neuroprotection in a mouse model of human tauopathy.

David W Hampton1, Daniel J Webber, Bilada Bilican, Michel Goedert, Maria Grazia Spillantini, Siddharthan Chandran.   

Abstract

Tau protein in a hyperphosphorylated state makes up the intracellular inclusions of several neurodegenerative diseases, including Alzheimer's disease and cases of frontotemporal dementia. Mutations in Tau cause familial forms of frontotemporal dementia, establishing that dysfunction of tau protein is sufficient to cause neurodegeneration and dementia. Transgenic mice expressing human mutant tau in neurons exhibit the essential features of tauopathies, including neurodegeneration and abundant filaments composed of hyperphosphorylated tau. Here we show that a previously described mouse line transgenic for human P301S tau exhibits an age-related, layer-specific loss of superficial cortical neurons, similar to what has been observed in human frontotemporal dementias. We also show that focal neural precursor cell implantation, resulting in glial cell differentiation, leads to the sustained rescue of cortical neurons. Together with evidence indicating that astrocyte transplantation may be neuroprotective, our findings suggest a beneficial role for glial cell-based repair in neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20668182      PMCID: PMC6633376          DOI: 10.1523/JNEUROSCI.0834-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

1.  In Vitro and In Vivo Proteomic Comparison of Human Neural Progenitor Cell-Induced Photoreceptor Survival.

Authors:  Melissa K Jones; Bin Lu; Dawn Zhaohui Chen; Weston R Spivia; Augustus T Mercado; Alexander V Ljubimov; Clive N Svendsen; Jennifer E Van Eyk; Shaomei Wang
Journal:  Proteomics       Date:  2019-01-02       Impact factor: 3.984

Review 2.  Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

Authors:  Adam L Boxer; Jin-Tai Yu; Lawrence I Golbe; Irene Litvan; Anthony E Lang; Günter U Höglinger
Journal:  Lancet Neurol       Date:  2017-06-13       Impact factor: 44.182

Review 3.  Don't forget astrocytes when targeting Alzheimer's disease.

Authors:  Jessica S Sadick; Shane A Liddelow
Journal:  Br J Pharmacol       Date:  2019-02-19       Impact factor: 8.739

Review 4.  Concise review: Can stem cells be used to treat or model Alzheimer's disease?

Authors:  Wesley W Chen; Mathew Blurton-Jones
Journal:  Stem Cells       Date:  2012-12       Impact factor: 6.277

5.  Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice.

Authors:  Noah R Johnson; Carlo Condello; Shenheng Guan; Abby Oehler; Julia Becker; Marta Gavidia; George A Carlson; Kurt Giles; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-04       Impact factor: 11.205

Review 6.  Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support.

Authors:  Samuel E Marsh; Mathew Blurton-Jones
Journal:  Neurochem Int       Date:  2017-02-20       Impact factor: 3.921

7.  Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder.

Authors:  Chiara Di Malta; John D Fryer; Carmine Settembre; Andrea Ballabio
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

8.  Heme and hemoglobin suppress amyloid β-mediated inflammatory activation of mouse astrocytes.

Authors:  Sitara B Sankar; Rebecca K Donegan; Kajol J Shah; Amit R Reddi; Levi B Wood
Journal:  J Biol Chem       Date:  2018-06-05       Impact factor: 5.157

9.  Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.

Authors:  Beatriz G Perez-Nievas; Thor D Stein; Hwan-Ching Tai; Oriol Dols-Icardo; Thomas C Scotton; Isabel Barroeta-Espar; Leticia Fernandez-Carballo; Estibaliz Lopez de Munain; Jesus Perez; Marta Marquie; Alberto Serrano-Pozo; Mathew P Frosch; Val Lowe; Joseph E Parisi; Ronald C Petersen; Milos D Ikonomovic; Oscar L López; William Klunk; Bradley T Hyman; Teresa Gómez-Isla
Journal:  Brain       Date:  2013-07-03       Impact factor: 13.501

Review 10.  The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy.

Authors:  Cheng-Cheng Zhang; Ang Xing; Meng-Shan Tan; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-09-12       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.